Dr. Filipe Gaspar has been appointed vice president of R&D at Hovione. Dr. Gaspar will lead teams based in Lisbon and New Jersey that serve client drug development projects. He will also head long-term product development strategies and collaborations, and will report to Guy Villax, Hovione’s chief executive officer.
 
Dr. Gaspar joined the company in 2003 as a manufacturing engineer and later became responsible for the technical leadership of spray drying technology. In 2004, Dr. Gaspar moved to R&D to start the Particle Engineering group, where he was involved in more than 120 projects from preclinical stage to commercial. In 2012, he moved to a business development role and spent a year based in NJ. Dr. Gaspar is the co-author and co-inventor of numerous publications, scientific presentations and patents. 

“We are very pleased to have Filipe running our R&D. Filipe brings great science and leadership skills. For the last 10 years Filipe has been the driving force behind our Particle Engineering, and if we have four new drugs today on the market it is because he and his team made sure we had the right capabilities, knowhow and ability to deliver” said Mr. Villax.